(E)-1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one

Catalog No. :
ACYPLK982
CAS No. :
112408-67-0
Molecular Formula :
C16H14O4
Molecular Weight :
270.28

IUPAC Name:(E)-1-(4-hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one

(E)-1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg97%$179.00Login to see priceInquiryInquiry
5mg97%$469.00Login to see priceInquiryInquiry
10mg97%$777.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
IUPAC Name(E)-1-(4-hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
MDL No.MFCD00800700
Molecular FormulaC16H14O4
Molecular Weight270.28
SMILESO=C(C1=CC=C(O)C=C1OC)/C=C/C2=CC=C(O)C=C2
InChI KeyPACBGANPVNHGNP-RUDMXATFSA-N
Synonym3-deoxysappanchalcone;(2E)-1-(4-Hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one;2'-Methoxyisoliquiritigenin;2-Propen-1-one, 1-(4-hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)-,(2E)-
CAS No.112408-67-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACYPLK982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYPLK982 route product structure diagram
    ACYPLK982112408-67-0
Inquiry

2. ACYPLK982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRZDC412 route compound structure diagram
    ACRZDC412123-08-0 In Stock
  4. Then
  5. ACYPLK982 route product structure diagram
    ACYPLK982112408-67-0
Inquiry

Comments (0)